Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001214659-25-000281·Juniper Investment Company, LLC
Schedule 13D ownership disclosure
Orthofix Medical Inc
Common stock, $0.10 par value per share · CUSIP: 68752M108
Event date: 2024-12-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Juniper Targeted Opportunity Fund, L.P.Reported CIK 0001524397
Shares: 1,554,725.00 · Class: 4.1%
- Juniper HF Investors II, LLC
Shares: 1,554,725.00 · Class: 4.1%
- Juniper Targeted Opportunities, L.P.Reported CIK 0001680619
Shares: 356,024.00 · Class: 0.9%
- Juniper Targeted Opportunity Investors, LLC
Shares: 356,024.00 · Class: 0.9%
- Juniper Multi-Strategy Fund, L.P.
Shares: 26,500.00 · Class: 0.1%
- Juniper HF Investors, LLC
Shares: 26,500.00 · Class: 0.1%
- Juniper Investment Company, LLCReported CIK 0001794034
Shares: 1,937,249.00 · Class: 5.1%
- Alexis P. MichasReported CIK 0001044005
Shares: 1,937,249.00 · Class: 5.1%
- John A. BartholdsonReported CIK 0001382909
Shares: 1,937,249.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-000281
- Form type
- SCHEDULE 13D
- Filer
- Juniper Investment Company, LLC
- CIK
- CIK 1794034
- Filed
- Jan 07, 2025
- Reporting period
- Dec 30, 2024
- Description
- Schedule 13D beneficial ownership